These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31423970)

  • 1. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.
    Okba NMA; Raj VS; Widjaja I; GeurtsvanKessel CH; de Bruin E; Chandler FD; Park WB; Kim NJ; Farag EABA; Al-Hajri M; Bosch BJ; Oh MD; Koopmans MPG; Reusken CBEM; Haagmans BL
    Emerg Infect Dis; 2019 Oct; 25(10):1868-1877. PubMed ID: 31423970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
    Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
    Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai.
    Lau SKP; Li KSM; Luk HKH; He Z; Teng JLL; Yuen KY; Wernery U; Woo PCY
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31969478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies.
    Okba NMA; Widjaja I; Li W; GeurtsvanKessel CH; Farag EABA; Al-Hajri M; Park WB; Oh MD; Reusken CBEM; Koopmans MPG; Bosch BJ; Haagmans BL
    Emerg Infect Dis; 2020 May; 26(5):1024-1027. PubMed ID: 32150528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.
    Park WB; Perera RA; Choe PG; Lau EH; Choi SJ; Chun JY; Oh HS; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Man Poon LL; Peiris M; Oh MD
    Emerg Infect Dis; 2015 Dec; 21(12):2186-9. PubMed ID: 26583829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.
    Wang W; Wang H; Deng Y; Song T; Lan J; Wu G; Ke C; Tan W
    Emerg Microbes Infect; 2016 Nov; 5(11):e113. PubMed ID: 27826140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
    Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
    J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
    Ko JH; Müller MA; Seok H; Park GE; Lee JY; Cho SY; Ha YE; Baek JY; Kim SH; Kang JM; Kim YJ; Jo IJ; Chung CR; Hahn MJ; Drosten C; Kang CI; Chung DR; Song JH; Kang ES; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2179-2186. PubMed ID: 28695355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA.
    Al-Amri SS; Hashem AM
    Methods Mol Biol; 2020; 2099():127-133. PubMed ID: 31883093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
    Harvey R; Mattiuzzo G; Hassall M; Sieberg A; Müller MA; Drosten C; Rigsby P; Oxenford CJ;
    Emerg Infect Dis; 2019 Oct; 25(10):1878-1883. PubMed ID: 31423969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
    Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia.
    Kasem S; Qasim I; Al-Hufofi A; Hashim O; Alkarar A; Abu-Obeida A; Gaafer A; Elfadil A; Zaki A; Al-Romaihi A; Babekr N; El-Harby N; Hussien R; Al-Sahaf A; Al-Doweriej A; Bayoumi F; Poon LLM; Chu DKW; Peiris M; Perera RAPM
    J Infect Public Health; 2018; 11(3):331-338. PubMed ID: 28993171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection.
    Park SW; Perera RA; Choe PG; Lau EH; Choi SJ; Chun JY; Oh HS; Song KH; Bang JH; Kim ES; Kim HB; Park WB; Kim NJ; Poon LL; Peiris M; Oh MD
    Euro Surveill; 2015; 20(41):. PubMed ID: 26538277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016.
    Ali M; El-Shesheny R; Kandeil A; Shehata M; Elsokary B; Gomaa M; Hassan N; El Sayed A; El-Taweel A; Sobhy H; Fasina FO; Dauphin G; El Masry I; Wolde AW; Daszak P; Miller M; VonDobschuetz S; Morzaria S; Lubroth J; Makonnen YJ
    Euro Surveill; 2017 Mar; 22(11):. PubMed ID: 28333616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
    Houser KV; Broadbent AJ; Gretebeck L; Vogel L; Lamirande EW; Sutton T; Bock KW; Minai M; Orandle M; Moore IN; Subbarao K
    PLoS Pathog; 2017 Aug; 13(8):e1006565. PubMed ID: 28817732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
    Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
    Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MERS-CoV in Camels but Not Camel Handlers, Sudan, 2015 and 2017.
    Farag E; Sikkema RS; Mohamedani AA; de Bruin E; Munnink BBO; Chandler F; Kohl R; van der Linden A; Okba NMA; Haagmans BL; van den Brand JMA; Elhaj AM; Abakar AD; Nour BYM; Mohamed AM; Alwaseela BE; Ahmed H; Alhajri MM; Koopmans M; Reusken C; Elrahman SHA
    Emerg Infect Dis; 2019 Dec; 25(12):2333-2335. PubMed ID: 31742534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    Kim MH; Kim HJ; Chang J
    PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya.
    Ommeh S; Zhang W; Zohaib A; Chen J; Zhang H; Hu B; Ge XY; Yang XL; Masika M; Obanda V; Luo Y; Li S; Waruhiu C; Li B; Zhu Y; Ouma D; Odendo V; Wang LF; Anderson DE; Lichoti J; Mungube E; Gakuya F; Zhou P; Ngeiywa KJ; Yan B; Agwanda B; Shi ZL
    Virol Sin; 2018 Dec; 33(6):484-492. PubMed ID: 30570714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.